nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.08.2015 | Article

Emergence of fusarioses in a university hospital in Turkey during a 20-year period

verfasst von: B. Dalyan Cilo, A. M. S. Al-Hatmi, S. Seyedmousavi, A. J. M. M. Rijs, P. E. Verweij, B. Ener, G. S. de Hoog, A. D. van Diepeningen

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 8/2015

Einloggen, um Zugang zu erhalten

Abstract

Fusarium species have started appearing increasingly as the main cause of infections, particularly in immunocompromised patients. In this study, we aimed to present the first epidemiological data from Turkey, analyze fusariosis cases that have been monitored in a university hospital during the past 20 years, identify the responsible Fusarium species, and determine antifungal susceptibilities. A total of 47 cases of fusariosis was included in the study. Fusarium isolates were identified by multilocus sequence typing (MLST). Antifungal susceptibility was tested by the broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) methodology. Of the Fusarium infections, 23.4 % were superficial, 44.7 % were locally invasive, and 31.9 % were disseminated. A significant increase was observed over the years. The Fusarium fujikuroi species complex (FFSC) proved to be the most frequent agent group (17 cases; 51.5 %), followed by the Fusarium solani species complex (FSSC) (14 cases; 42.4 %), the Fusarium dimerum species complex (FDSC), and the Fusarium oxysporum species complexes (FOSC) (one case each). Amphotericin B had the highest in vitro activity against all species. Voriconazole and posaconazole showed interspecies variability across and within Fusarium species complexes. In conclusion, our data support the fact that regional differences exist in the distribution of the Fusarium species and that species-specific differences are observed in antifungal susceptibility patterns. The monitoring of local epidemiological data by determining fungal identity and susceptibility are of importance in guiding the clinical follow-up of patients.

Nur mit Berechtigung zugänglich

Leslie JF, Summerell BA (2006) The Fusarium laboratory manual. Blackwell, LondonCrossRef

O’Donnell K, Sutton DA, Fothergill A, McCarthy D, Rinaldi MG, Brandt ME et al (2008) Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol 46:2477–2490PubMedCentralPubMedCrossRef

O’Donnell K, Gueidan C, Sink S, Johnston PR, Crous PW, Glenn A et al (2009) A two-locus DNA sequence database for typing plant and human pathogens within the Fusarium oxysporum species complex. Fungal Genet Biol 46:936–948PubMedCrossRef

O’Donnell K, Sutton DA, Rinaldi MG, Gueidan C, Crous PW, Geiser DM (2009) Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum–F. equiseti and F. chlamydosporum species complexes within the United States. J Clin Microbiol 47:3851–3861PubMedCentralPubMedCrossRef

O’Donnell K, Sutton DA, Rinaldi MG, Sarver BA, Balajee SA, Schroers HJ et al (2010) Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 48:3708–3718PubMedCentralPubMedCrossRef

Geiser DM, Aoki T, Bacon CW, Baker SE, Bhattacharyya MK, Brandt ME et al (2013) One fungus, one name: defining the genus Fusarium in a scientifically robust way that preserves longstanding use. Phytopathology 103:400–408PubMedCrossRef

de Hoog GS, Haase G, Chaturvedi V, Walsh TJ, Meyer W, Lackner M (2013) Taxonomy of medically important fungi in the molecular era. Lancet Infect Dis 13:385–386PubMedCrossRef

Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL et al (2010) International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 54:4446–4450PubMedCentralPubMedCrossRef

Migheli Q, Balmas V, Harak H, Sanna S, Scherm B, Aoki T et al (2010) Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in northern and central Italy. J Clin Microbiol 48:1076–1084PubMedCentralPubMedCrossRef

10.

van Diepeningen AD, Feng P, Ahmed S, Sudhadham M, Bunyaratavej S, de Hoog GS (2015) Spectrum of Fusarium infections in tropical dermatology evidenced by multilocus sequencing typing diagnostics. Mycoses 58(1):48–57PubMedCrossRef

11.

Kredics L, Narendran V, Shobana CS, Vágvölgyi C, Manikandan P; Indo-Hungarian Fungal Keratitis Working Group (2015) Filamentous fungal infections of the cornea: a global overview of epidemiology and drug sensitivity. Mycoses 58:243–260PubMedCrossRef

12.

Avelino-Silva VI, Ramos JF, Leal FE, Testagrossa L, Novis YS (2015) Disseminated Fusarium infection in autologous stem cell transplant recipient. Braz J Infect Dıs 19:90–93PubMedCrossRef

13.

Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20:695–704PubMedCentralPubMedCrossRef

14.

van Diepeningen AD, Al-Hatmi AMS, Brankovics B, de Hoog GS (2014) Taxonomy and clinical spectra of Fusarium species: where do we stand in 2014? Curr Clin Microbiol Rep 1:10–18CrossRef

15.

Nucci M, Marr KA, Vehreschild MJGT, de Souza CA, Velasco E, Cappellano P et al (2014) Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect 20:580–585PubMedCrossRef

16.

Azor M, Gené J, Cano J, Guarro J (2007) Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother 51:1500–1503PubMedCentralPubMedCrossRef

17.

Al-Hatmi AMS, van Diepeningen AD, Curfs-Breuker I, de Hoog GS, Meis JF (2015) Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother 70:1068–1071. doi:10.1093/jac/dku505 PubMed

18.

Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P et al (2014) ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect 20(Suppl 3):27–46PubMedCrossRef

19.

Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL (2008) Antifungal susceptibility profile of clinical Fusarium spp. Isolates identified by molecular methods. J Antimicrob Chemother 61:805–809PubMedCrossRef

20.

Möller EM, Bahnweg G, Sandermann H, Geiger HH (1992) A simple and efficient protocol for isolation of high molecular weight DNA from filamentous fungi, fruit bodies, and infected plant tissues. Nucleic Acids Res 20:6115–6116PubMedCentralPubMedCrossRef

21.

White TJ, Bruns TD, Lee SB, Taylor JW (1990) Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols: a guide to methods and applications. Academic Press, New York, pp 315–322

22.

Geiser DM, del Mar Jiménez-Gasco M, Kang S, Makalowska I, Veeraraghavan N, Ward TJ et al (2004) FUSARIUM-ID v. 1.0: a DNA sequence database for identifying Fusarium. Eur J Plant Pathol 110:473–479CrossRef

23.

Schroers HJ, O’Donnell K, Lamprecht SC, Kammeyer PL, Johnson S, Sutton DA et al (2009) Taxonomy and phylogeny of the Fusarium dimerum species group. Mycologia 101:44–70PubMedCrossRef

24.

Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard—Second edition. CLSI document M38-A2. CLSI, Wayne

25.

Mansur AT, Artunkal S, Ener B (2011) Fusarium oxysporum infection of stasis ulcer: eradication with measures aimed to improve stasis. Mycoses 54:e205–e207PubMedCrossRef

26.

Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B et al (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91:1068–1075PubMed

27.

Nucci M, Varon AG, Garnica M, Akiti T, Barreiros G, Trope BM et al (2013) Increased incidence of invasive fusariosis with cutaneous portal of entry, Brazil. Emerg Infect Dis 19:1567–1572PubMedCentralPubMedCrossRef

28.

Guinvarc’h A, Guilbert L, Marmorat-Khuong A, Lavarde V, Chevalier P, Amrein C et al (1998) Disseminated Fusarium solani infection with endocarditis in a lung transplant recipient. Mycoses 41:59–61PubMedCrossRef

29.

Park BJ, Pappas PG, Wannemuehler KA, Alexander BD, Anaissie EJ, Andes DR et al (2011) Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006. Emerg Infect Dis 17:1855–1864PubMedCentralPubMedCrossRef

30.

Edupuganti S, Rouphael N, Mehta A, Eaton M, Heller JG, Bressler A et al (2011) Fusarium falciforme vertebral abscess and osteomyelitis: case report and molecular classification. J Clin Microbiol 49:2350–2353PubMedCentralPubMedCrossRef

31.

Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic J, Ivanovic D et al (2014) European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis 33:1623–1630PubMedCrossRef

32.

Kebabcı N, van Diepeningen AD, Ener B, Ersal T, Meijer M, Al-Hatmi AMS et al (2014) Fatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay. Mycoses 57:249–255PubMedCrossRef

33.

Ersal T, Al-Hatmi AMS, Cilo BD, Curfs-Breuker I, Meis JF, Özkalemkaş F et al (2015) Fatal disseminated infection with Fusarium petroliphilum. Mycopathologia 179:119–124PubMedCrossRef

34.

Chi CC, Wang SH, Chou MC (2005) The causative pathogens of onychomycosis in southern Taiwan. Mycoses 48:413–420PubMedCrossRef

35.

Castro López N, Casas C, Sopo L, Rojas A, Del Portillo P, Cepero de García MC et al (2009) Fusarium species detected in onychomycosis in Colombia. Mycoses 52:350–356

36.

Ninet B, Jan I, Bontems O, Léchenne B, Jousson O, Lew D et al (2005) Molecular identification of Fusarium species in onychomycoses. Dermatology 210:21–25PubMedCrossRef

37.

Muhammed M, Coleman JJ, Carneiro HA, Mylonakis E (2011) The challenge of managing fusariosis. Virulence 2:91–96PubMedCentralPubMedCrossRef

Titel: Emergence of fusarioses in a university hospital in Turkey during a 20-year period
verfasst von: B. Dalyan Cilo
A. M. S. Al-Hatmi
S. Seyedmousavi
A. J. M. M. Rijs
P. E. Verweij
B. Ener
G. S. de Hoog
A. D. van Diepeningen
Publikationsdatum: 01.08.2015
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 8/2015
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-015-2405-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Emergence of fusarioses in a university hospital in Turkey during a 20-year period

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2015

A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand

Performance of Gram staining on blood cultures flagged negative by an automated blood culture system

The Uni-Gold™ Streptococcus pneumoniae urinary antigen test: an interassay comparison with the BinaxNOW® Streptococcus pneumoniae test on consecutive urine samples and evaluation on patients with bacteremia

Application of immobilized synthetic anti-lipopolysaccharide peptides for the isolation and detection of bacteria

An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread

Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin